Chapter 47- Lipid-Lowering Agents
1. It has been found that some populations have a higher incidence of CAD than
others. What patient population would have the greatest chance of developing CAD
as determined by total cholesterol?
A) A 32-year-old Asian American with total cholesterol of 120 mg/dl
B) A 62-year-old White American with total cholesterol of 260 mg/dl
C) A 48-year-old African American with total cholesterol of 198 mg/dl
D) A 26-year-old Native American with total cholesterol of 150 mg/dl
2. You are assessing a patient who is taking cholestyramine (Questran) 6 times a day.
You will most likely formulate what nursing diagnosis?
A) Acute pain related to CNS and GI effects
B) Constipation related to GI effects
C) Non-compliance related to number of times medication is taken
D) Deficient knowledge regarding drug therapy
3. A patient calls the clinic and talks to the nurse. They tell they have been taking
colesevelem (Welchol) for six months. The patient tells the nurse that they are having
small amounts of bright, red rectal bleeding and they are concerned. What would an
appropriate response from the nurse be?
A) “I should let your physician know immediately!”
B) “Don't worry about it. This can happen some time.”
C) “Stop taking the medication now! This is a serious adverse effect.”
D) “The bleeding may be coming from hemorrhoids. We should check this out.”
4. You are engaged in patient teaching with a patient who has just been prescribed a bile
acid sequestrant. You teach the patient that he may mix his lipid-lowering agent with
a carbonated beverage. What bile acid sequestrant is the patient taking?
A) Cholestyramine (Questran)
B) Colesevelem (Welchol)
C) Colestipol (Colestid)
D) Ezetimibe (Zetia)
5. Your patient asks you what will the atorvastatin (Lipitor) they are prescribed do for
them. What is an expected outcome for this patient?
A) Decrease in serum cholesterol only
B) Decrease in serum cholesterol and LDL levels
C) Decrease in sitosterol and serum cholesterol
D) Decrease in camperterol and LDL levels
, 6. The nurse is taking a health history on a 38-year-old male bar owner who is taking
atorvastatin (Lipitor) for high cholesterol. The nurse will be sure to ask a specific
group of questions regarding the patient's use of what?
A) Alcohol
B) Nicotine
C) Caffeine
D) Herbal therapy
7. A 9-year-old child has received an order for provastatin (Pravachol) 40 mg/d PO for
genetically linked hyperlipidemia. In preparation for patient teaching concerning
this drug, the nurse's initial action will be what?
A) Ask the parents to be present for the teaching session
B) Determine the appropriate time to discuss the drug with the patient
C) Question the doctor concerning the order
D) Review information in the nurse drug reference book concerning the drug
8. A student asks the nursing instructor what the most common adverse effects
of ezetimibe (Zetia) are. What would be the instructor's best response?
A) Bloating and flank pain
B) Neuropathy and flatulence
C) Mild abdominal pain and diarrhea
D) Constipation and flank pain
9. You are discharging a patient home on HMG-CoA inhibitor therapy. What statement
by the patient demonstrates that they have a clear understanding of the teaching you
have done?
A) “I won't need to follow that diet any more because this drug will take care of
my lipids.”
B) “I should take this drug at bedtime, since my body makes lipids mostly at night.”
C) “This drug will protect me from having a heart attack or stroke.”
D) “I should take this drug first thing in the morning with a full glass of water.”
10. A patient has been prescribed atorvastatin (Lipitor) comes to the clinic with
complaints of acute muscle pain not associated with exercise or injury, which indicates
potential rhabdomyolysis. The nurse knows that the use of atorvastatin with which of
the following products places the patient at risk for rhabdomyolysis?
A) Over-the-counter (OTC) drug use
B) Use of ginseng
C) Grapefruit juice consumption
D) Use of saw palmetto
P ag e 2
This study source was downloaded by 100000829015476 from CourseHero.com o n 0 3 -2 9-2022 21:16:50 GMT
https://www.coursehero.com/file/8830166/Chapter-47-Lipid-Lowering-Agents/
1. It has been found that some populations have a higher incidence of CAD than
others. What patient population would have the greatest chance of developing CAD
as determined by total cholesterol?
A) A 32-year-old Asian American with total cholesterol of 120 mg/dl
B) A 62-year-old White American with total cholesterol of 260 mg/dl
C) A 48-year-old African American with total cholesterol of 198 mg/dl
D) A 26-year-old Native American with total cholesterol of 150 mg/dl
2. You are assessing a patient who is taking cholestyramine (Questran) 6 times a day.
You will most likely formulate what nursing diagnosis?
A) Acute pain related to CNS and GI effects
B) Constipation related to GI effects
C) Non-compliance related to number of times medication is taken
D) Deficient knowledge regarding drug therapy
3. A patient calls the clinic and talks to the nurse. They tell they have been taking
colesevelem (Welchol) for six months. The patient tells the nurse that they are having
small amounts of bright, red rectal bleeding and they are concerned. What would an
appropriate response from the nurse be?
A) “I should let your physician know immediately!”
B) “Don't worry about it. This can happen some time.”
C) “Stop taking the medication now! This is a serious adverse effect.”
D) “The bleeding may be coming from hemorrhoids. We should check this out.”
4. You are engaged in patient teaching with a patient who has just been prescribed a bile
acid sequestrant. You teach the patient that he may mix his lipid-lowering agent with
a carbonated beverage. What bile acid sequestrant is the patient taking?
A) Cholestyramine (Questran)
B) Colesevelem (Welchol)
C) Colestipol (Colestid)
D) Ezetimibe (Zetia)
5. Your patient asks you what will the atorvastatin (Lipitor) they are prescribed do for
them. What is an expected outcome for this patient?
A) Decrease in serum cholesterol only
B) Decrease in serum cholesterol and LDL levels
C) Decrease in sitosterol and serum cholesterol
D) Decrease in camperterol and LDL levels
, 6. The nurse is taking a health history on a 38-year-old male bar owner who is taking
atorvastatin (Lipitor) for high cholesterol. The nurse will be sure to ask a specific
group of questions regarding the patient's use of what?
A) Alcohol
B) Nicotine
C) Caffeine
D) Herbal therapy
7. A 9-year-old child has received an order for provastatin (Pravachol) 40 mg/d PO for
genetically linked hyperlipidemia. In preparation for patient teaching concerning
this drug, the nurse's initial action will be what?
A) Ask the parents to be present for the teaching session
B) Determine the appropriate time to discuss the drug with the patient
C) Question the doctor concerning the order
D) Review information in the nurse drug reference book concerning the drug
8. A student asks the nursing instructor what the most common adverse effects
of ezetimibe (Zetia) are. What would be the instructor's best response?
A) Bloating and flank pain
B) Neuropathy and flatulence
C) Mild abdominal pain and diarrhea
D) Constipation and flank pain
9. You are discharging a patient home on HMG-CoA inhibitor therapy. What statement
by the patient demonstrates that they have a clear understanding of the teaching you
have done?
A) “I won't need to follow that diet any more because this drug will take care of
my lipids.”
B) “I should take this drug at bedtime, since my body makes lipids mostly at night.”
C) “This drug will protect me from having a heart attack or stroke.”
D) “I should take this drug first thing in the morning with a full glass of water.”
10. A patient has been prescribed atorvastatin (Lipitor) comes to the clinic with
complaints of acute muscle pain not associated with exercise or injury, which indicates
potential rhabdomyolysis. The nurse knows that the use of atorvastatin with which of
the following products places the patient at risk for rhabdomyolysis?
A) Over-the-counter (OTC) drug use
B) Use of ginseng
C) Grapefruit juice consumption
D) Use of saw palmetto
P ag e 2
This study source was downloaded by 100000829015476 from CourseHero.com o n 0 3 -2 9-2022 21:16:50 GMT
https://www.coursehero.com/file/8830166/Chapter-47-Lipid-Lowering-Agents/
